The membrane-active antimicrobial peptide 6K-F17 effectively inhibited biofilm production in Pseudomonas aeruginosa PAO1 and four multidrug-resistant (MDR) isolates from chronically infected CF individuals, as well as significantly reducing biofilm volume in both PAO1 and MDR isolates [29]. The gene discussed is SMOX; the disease is cystic fibrosis.